Goss Wealth Management »

Atrium Therapeutics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6k 123 13.37

More positions owned by Goss Wealth Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wal-Mart Stores (WMT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
Exxon Mobil Corporation (XOM)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Chevron Corporation (CVX)

View all positions for Goss Wealth Management

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics